The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3

The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3. has Hexachlorophene been considered absent in Canada, the United States, and Hexachlorophene countries in Western Europe. However, individuals in the countries where hepatitis E is nonendemic with no known history of traveling to areas of endemicity have contracted the disease (6, 13, 23, 38, 40), suggesting that HEV may be more widespread than previously recognized. Recently in the United States, two distinct HEVs have been isolated from two patients with acute hepatitis E (designated US-1 and US-2) (18, 32). The US-1 sequence is substantially divergent from other known human HEVs, with a sequence identity of only 74% (32). In parallel with this study, an HEV has been identified from pigs in Illinois (26), and surprisingly, this swine isolate of HEV is genetically and antigenically close to the Hexachlorophene US-1 strain of human HEV. The sequence similarity between the US-1 human and swine HEV genomes is approximately 97 and 93% in open reading frame 2 (ORF2) and ORF3, respectively (26, 32). Furthermore, swine HEV is able Hexachlorophene to infect primates under experimental conditions (25). These findings implicate a CRYAA possible transmission of the virus from pigs to humans. The potential for HEV to cause disease in swine has not been adequately evaluated. Swine has been considered to be a donor animal species for xenotransplantation, and organ transplantation might directly transmit swine viruses to a human recipient who may pose further xenozoonotic risks in the community (41). Also, HEV from swine might sometimes be transmitted to humans through environmental contact. Accordingly, we have serologically surveyed Canadian swine herds for hepatitis E. In this communication, we report that swine HEV is highly prevalent in Canadian swine herds and describe a novel genotypic variant of swine HEV isolated from Canadian pigs. MATERIALS AND METHODS Serum specimens. Serum samples were collected from 6-month-old, healthy slaughter hogs in the Canadian provinces of Alberta, Saskatchewan, Ontario, Quebec, and Prince Edward Island. These pigs represented major pig production areas in Canada. Human serum samples were obtained from patients admitted to the Royal University Hospital Hexachlorophene in Saskatoon, Saskatchewan, Canada, during the period of 1998 to 2000. These human serum samples represented a randomized collection from individuals who tested negative for human immunodeficiency virus and hepatitis C. Both swine and human serum samples were stored at ?70C until tested for antibody. Enzyme-linked immunoassays. Antibodies to HEV in human sera were determined using a commercial hepatitis E antibody detection kit according to the manufacturer’s instructions (Hepatitis E [rDNA] Antigen Abbott HEV EIA kit; Abbott GmbH, Biesbaden-Delkenheim, Germany). Antibodies to HEV in swine sera were also tested using the commercial kit but with slight modifications. Briefly, pig serum was diluted in phosphate-buffered saline at 1:400 and incubated for 60 min at 40C with a polystyrene bead coated with the recombinant HEV antigen provided with the kit. The bead was washed four times with 4 ml of distilled water per wash. The bead was transferred to a fresh tube and incubated for 1 h at 40C with a 1:400 dilution of rabbit anti-swine antibody coupled with horseradish peroxidase (Kirkegaard & Perry Laboratories, Gaithersburg, Md.). The bead was washed four times again with 4 ml of water each and transferred to a new tube. Substrate was prepared by adding 2.56 mg of JM109 cells transformed with pGEX-HEVF3 were grown at 37C in Luria-Bertani medium with vigorous shaking. When the culture reached an optical density of 0.6 at 600 nm, isopropylthio–d-galactoside (IPTG) was added to a final concentration of 2 mM, and the culture was further incubated for an additional 6 h. Cells were collected by low-speed centrifugation at 500 for 20 min, and the cell pellet was resuspended in 4 ml of 25% sucrose in 50 mM Tris-HCl (pH 8.0). After two freeze-thaw cycles, 10 mg of lysozyme was added and the suspension was incubated for 10 min on ice followed by addition of 30 ml of 2 RIPA-TET buffer (5:4; 2 RIPA is 20 mM Tris-HCl [pH 8.0], 300 mM NaCl, and 2% sodium deoxycholate; TET is 100 mM Tris-HCl [pH 8.0], 50 mM EDTA, and 2% Triton X-100). The mixture was sonicated at the highest scale (model W-385; Ultrasonics Inc., Farmingdale, N.Y.) and centrifuged at 12,000 rpm for 15 min using an SS34 rotor in the high-speed centrifuge (Sorvall RC-5B; Du Pont Instruments, Wilmington, Del.). The pellet as insoluble aggregates was resuspended in water and.